Skip to main content
. Author manuscript; available in PMC: 2010 Jul 27.
Published in final edited form as: Arch Surg. 2009 Jul;144(7):649–655. doi: 10.1001/archsurg.2009.116

Table III.

Final histopathology of all FNAB cytology subdivisions

Preoperative FNAB Cytology
Final Diagnosis Benign Inconclusive Malignant Non-diagnostic
n 52 23 11 11
Carcinoma (%)
 PTC 4 (7.7%) 1 (4.3%) 8 (72.7%) 2 (18.2%)
 FC 0 1 (4.3%) 0 0
 HCC 0 2 (8.7%) 0 1 (9.1%)
 MTC 0 0 1 (9.1%) 0
 Anaplastic 0 0 1 (9.1%) 0
Benign follicular neoplasm (%)
 FA 18 (34.6%) 13 (56.6%) 0 5 (45.4%)
 HCA 4 (7.7%) 3 (13.1%) 0 0
Benign pathology (%)
 MNG 17 (32.7%) 2 (8.7%) 0 1 (9.1%)
 Benign nodule/cyst 9 (17.3%) 1 (4.3%) 0 2 (18.2%)
 Sarcoid/noncaseating granuloma 0 0 1 (9.1%) 0

PTC, papillary thyroid carcinoma; FTC, follicular thyroid carcinoma; HCC, Hürthle cell carcinoma; MTC, medullary thyroid carcinoma; FA, follicular adenoma; HCA, Hürthle cell carcinoma; MNG, multinodular gouter